Pooled analysis of multiple sclerosis findings on multisite 7 Tesla MRI: Protocol and initial observations
- PMID: 39169546
- PMCID: PMC11339124
- DOI: 10.1002/hbm.26816
Pooled analysis of multiple sclerosis findings on multisite 7 Tesla MRI: Protocol and initial observations
Abstract
Although 7 T MRI research has contributed much to our understanding of multiple sclerosis (MS) pathology, most prior data has come from small, single-center studies with varying methods. In order to truly know if such findings have widespread applicability, multicenter methods and studies are needed. To address this, members of the North American Imaging in MS (NAIMS) Cooperative worked together to create a multicenter collaborative study of 7 T MRI in MS. In this manuscript, we describe the methods we have developed for the purpose of pooling together a large, retrospective dataset of 7 T MRIs acquired in multiple MS studies at five institutions. To date, this group has contributed five-hundred and twenty-eight 7 T MRI scans from 350 individuals with MS to a common data repository, with plans to continue to increase this sample size in the coming years. We have developed unified methods for image processing for data harmonization and lesion identification/segmentation. We report here our initial observations on intersite differences in acquisition, which includes site/device differences in brain coverage and image quality. We also report on the development of our methods and training of image evaluators, which resulted in median Dice Similarity Coefficients for trained raters' annotation of cortical and deep gray matter lesions, paramagnetic rim lesions, and meningeal enhancement between 0.73 and 0.82 compared to final consensus masks. We expect this publication to act as a resource for other investigators aiming to combine multicenter 7 T MRI datasets for the study of MS, in addition to providing a methodological reference for all future analysis projects to stem from the development of this dataset.
Keywords: 7 T; multicenter; multiple sclerosis.
© 2024 The Author(s). Human Brain Mapping published by Wiley Periodicals LLC.
Conflict of interest statement
Dr. Harrison has received research funding from EMD‐Serono and Roche‐Genentech. Dr. Harrison has received consulting fees from TG Therapeutics and EMD‐Serono and receives royalties from Up To Date, Inc. Dr. Kolind has received research support from Roche‐Genentech, Sanofi‐Genzyme and Biogen. Dr. Beck has received consulting fees from EMD‐Serono. Dr. Reich has received research funding from Abata and Sanofi. Dr. Bakshi has received speaking honoraria from EMD Serono and research support from Bristol Myers Squibb, EMD Serono, and Novartis. Dr. Narayanan has received research funding from F. Hoffman LaRoche and Immunotec, is a consultant for Sana Biotech and is a part‐time employee of NeuroRx Research. Dr. Traboulsee has received consulting fees from Roche‐Genentech, Sanofi‐Genzyme, Serono, Biogen and has research funding from Roche‐Genentech and Sanofi. Dr. Fetco is an employee of NeuroRx Research. Dr. Zurawski has received research support from the Elizabeth A. Kremer Research Foundation, Novartis Pharmaceuticals, NIH, I‐Mab Biopharma and the Race to Erase MS Foundation. Drs. Choi, Rudko, Schindler, and Tauhid have nothing to disclose. Ms. Callen and Quatrucci and Mr. Greenwald have nothing to disclose.
Figures







References
-
- Bagnato, F. , Sati, P. , Hemond, C. C. , Elliott, C. , Gauthier, S. A. , Harrison, D. M. , Mainero, C. , Oh, J. , Pitt, D. , Shinohara, R. T. , Smith, S. A. , Trapp, B. , Azevedo, C. J. , Calabresi, P. A. , Henry, R. G. , Laule, C. , Ontaneda, D. , Rooney, W. D. , Sicotte, N. L. , … Absinta, M. (2024). Imaging chronic active lesions in multiple sclerosis: A consensus statement. Brain, 2024, awae013. - PMC - PubMed
Publication types
MeSH terms
Grants and funding
- R01NS122980/NS/NINDS NIH HHS/United States
- R01 NS122980/NS/NINDS NIH HHS/United States
- Novartis
- Center for Neuroinflammation and Experimental Therapeutics at the University of Pennsylvania
- Race to Erase MS
- FG-2208-40289/National Multiple Sclerosis Society
- PJT153005/CAPMC/ CIHR/Canada
- 20220/Conrad N. Hilton Foundation
- FRN 84367/CAPMC/ CIHR/Canada
- EMD Serono
- ZIA NS003119/ImNIH/Intramural NIH HHS/United States
- TA-2109-38412/National Multiple Sclerosis Society
- R01 NS104403/NS/NINDS NIH HHS/United States
- K23 NS072366/NS/NINDS NIH HHS/United States
- Roche
- R01NS104403/NS/NINDS NIH HHS/United States
- Bristol-Myers Squibb
- ZIANS003119/NH/NIH HHS/United States
- National MS Society
- K23NS072366/NS/NINDS NIH HHS/United States
LinkOut - more resources
Full Text Sources
Medical